Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-561,814
Closed -$55.3M 85
2025
Q2
$55.3M Buy
561,814
+3,400
+0.6% +$322K 7.87% 1
2025
Q1
$51.7M Sell
558,414
-45,151
-7% -$4.16M 6.77% 1
2024
Q4
$54.8M Buy
603,565
+1,950
+0.3% +$179K 5.92% 1
2024
Q3
$58.1M Sell
601,615
-100,425
-14% -$9.8M 5.85% 1
2024
Q2
$64.4M Sell
702,040
-1,837
-0.3% -$170K 6.53% 1
2024
Q1
$64.9M Sell
703,877
-6,820
-1% -$639K 6.74% 3
2023
Q4
$67.6M Buy
710,697
+461,368
+185% +$43.1M 6.67% 4
2023
Q3
$23.3M Buy
249,329
+164,029
+192% +$15.2M 2.08% 19
2023
Q2
$7.8M Buy
+85,300
New +$7M 0.67% 33

Other funds holding AMED

Water Island Capital's AMED Position: Q3 2025 in Review

Water Island Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 561,814 shares — an estimated $55.3M sold.

Water Island Capital first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $67.6M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Water Island Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Water Island Capital sold 561,814 Amedisys shares in Q3 2025, an estimated $55.3M.
  • Water Island Capital first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
  • Water Island Capital's Amedisys position peaked at $67.6M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Water Island Capital's 13F filing for Q3 2025, filed 14 Nov 2025.